$辉瑞(PFE)$ C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.